Entrapment of peptidoglycans and adamantyltripeptides into liposomes: An HPLC assay for determination of encapsulation efficiency

被引:23
作者
Frkanec, R
Travas, D
Krstanovic, M
Spoljar, BH
Ljevakovic, D
Vranesic, B
Frkanec, L
Tomasic, J
机构
[1] Inst Immunol Inc, Res & Dev, Hanoi 10000, Vietnam
[2] Inst Immunol Inc, Dept Qual Control, Hanoi 10000, Vietnam
[3] Inst Immunol Inc, Dept Qual Assurance, Hanoi 10000, Vietnam
[4] Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia
关键词
peptidoglycan monomer; adamantyltripeptides; liposomes; HPLC encapsulation;
D O I
10.1081/LPR-120026452
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The encapsulation of different immunomodulating peptides, the peptidoglycan monomer, its semisynthetic derivatives (Adamant-1-yl)-acetyl-peptidoglycan monomer and Boc-Tyr-peptidoglycan monomer, respectively, and of two diastereoisomers of adamantyltripeptides into the large negatively charged multilamellar liposomes was investigated. The reproducible quantitative method using HPLC was established for the determination of the entrapped compounds. It was shown that the tested compounds could be efficiently incorporated into liposomes using either the film or modified film method. The results confirmed that the peptidoglycans with lipophilic substituents and particularly the adamantyltripeptides were incorporated into liposomes with higher efficiency than the peptidoglycan monomer using either of the described methods. Liposome preparations were stable at 4degreesC up to seven days as shown by minimal leaking of the entrapped material.
引用
收藏
页码:279 / 294
页数:16
相关论文
共 55 条
[1]  
Allison AC, 1997, NATO ADV SCI I A-LIF, V293, P1
[2]  
Alpar HO, 2000, STP PHARMA SCI, V10, P269
[3]   LIPOSOMES AS CARRIERS OF ANTIGENS AND ADJUVANTS [J].
ALVING, CR .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 140 (01) :1-13
[4]   Immunogenicity and protectivity of a new liposomal hepatitis A vaccine [J].
Ambrosch, F ;
Wiedermann, G ;
Jonas, S ;
Althaus, B ;
Finkel, B ;
Gluck, R ;
Herzog, C .
VACCINE, 1997, 15 (11) :1209-1213
[5]   LIPOSOMES AS VACCINE CARRIERS - INCORPORATION OF SOLUBLE AND PARTICULATE ANTIGENS IN GIANT VESICLES [J].
ANTIMISIARIS, SG ;
JAYASEKERA, P ;
GREGORIADIS, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 166 (02) :271-280
[6]   LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE UP-REGULATES MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR GENE-EXPRESSION IN HUMAN MONOCYTES AT THE TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL LEVELS [J].
ASANO, T ;
MATSUSHIMA, K ;
KLEINERMAN, ES .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 38 (01) :16-22
[7]   SYNTHETIC IMMUNOADJUVANTS - APPLICATION TO NONSPECIFIC HOST STIMULATION AND POTENTIATION OF VACCINE IMMUNOGENICITY [J].
AZUMA, I .
VACCINE, 1992, 10 (14) :1000-1006
[8]   Piroxicam encapsulated in liposomes: Characterization and in vivo evaluation of topical anti-inflammatory effect [J].
Canto, GS ;
Dalmora, SL ;
Oliveira, AG .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (12) :1235-1239
[9]   CHEMOIMMUNOTHERAPY OF MURINE LIVER METASTASES WITH 5-FLUOROURACIL IN COMBINATION WITH LIPOSOME-ENCAPSULATED MURAMYL DIPEPTIDE [J].
DAEMEN, T ;
DONTJE, BHJ ;
REGTS, J ;
SCHERPHOF, GL .
JOURNAL OF IMMUNOTHERAPY, 1993, 13 (01) :31-35
[10]  
DASIC G, 1994, INT J ONCOL, V5, P275